Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Arrhythmias with normal heart rate]

K Segawa1, N Yoshimoto, H Matsuo

  • 13rd Department of Internal Medicine, Saitama Medical Center, Saitama Medical School.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|August 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Isolation and identification of C-type natriuretic peptide in human monocytic cell line, THP-1.

Biochemical and biophysical research communications·1992
Same author

Stable expression of natriuretic peptide receptors: effects of HS-142-1, a non-peptide ANP antagonist.

Biochemical and biophysical research communications·1992
Same author

Gestational age-dependent dual action of epidermal growth factor on human placenta early in gestation.

The Journal of clinical endocrinology and metabolism·1992
Same author

[The prevalence and the clinical characteristics of silent myocardial ischemia detected by stress thallium scintigraphy].

Kaku igaku. The Japanese journal of nuclear medicine·1992
Same author

Inherited heterozygous protein C deficiency and dysfunctional protein S with recurrent venous thrombotic diseases: a study of three generations of a Japanese family.

Internal medicine (Tokyo, Japan)·1992
Same author

Cloning and characterization of an androgen-induced growth factor essential for the androgen-dependent growth of mouse mammary carcinoma cells.

Proceedings of the National Academy of Sciences of the United States of America·1992

Premature ventricular complexes can increase sudden cardiac death risk, especially post-myocardial infarction. Antiarrhythmic therapy effectiveness is debated, shifting focus to quality of life for less severe arrhythmias.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Pharmacology

Context:

  • Ventricular arrhythmias, particularly premature ventricular complexes (PVCs), are linked to adverse cardiac events.
  • The risk is amplified in patients with a history of myocardial infarction.
  • Traditional antiarrhythmic strategies aimed at suppressing ventricular arrhythmias have yielded controversial results.

Purpose:

  • To review the current understanding of ventricular arrhythmias and their management.
  • To discuss the evolving therapeutic approaches, considering the differing actions of antiectopic and antifibrillatory drugs.
  • To re-evaluate the indications for antiarrhythmic therapy based on patient prognosis and quality of life.

Summary:

  • Premature ventricular complexes are a significant risk factor for sudden cardiac death and ventricular tachycardia in specific contexts.

Related Experiment Videos

  • The CAST study highlighted unexpected outcomes from empirical antiarrhythmic drug use.
  • Emerging evidence differentiates antiectopic and antifibrillatory effects, suggesting amiodarone as a potential empiric therapy.
  • Arrhythmias with a normal heart rate generally pose less risk to survival.

    • Impact:

    • Challenges the long-held hypothesis that suppressing all ventricular arrhythmias improves patient prognosis.
    • Suggests a paradigm shift in antiarrhythmic therapy, prioritizing quality of life for non-life-threatening arrhythmias.
    • Informs clinical decision-making regarding the use of antiarrhythmic agents, particularly in post-myocardial infarction patients.